Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Cash from Operations (2024 - 2025)

Carlsmed (CARL) has disclosed Cash from Operations for 2 consecutive years, with 5321000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations fell 26.6% year-over-year to 5321000.0, compared with a TTM value of 25563000.0 through Dec 2025, changed N/A, and an annual FY2025 reading of 28977000.0, down 13.79% over the prior year.
  • Cash from Operations was 5321000.0 for Q4 2025 at Carlsmed, up from 8459000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 4203000.0 in Q4 2024 and bottomed at 8459000.0 in Q3 2025.